Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice
Bone Marrow Transplant
.
2024 Nov 18.
doi: 10.1038/s41409-024-02476-z.
Online ahead of print.
Authors
Michelle M Chin
1
,
John S Tamaresis
2
,
Laura J Johnston
3
,
Robert Lowsky
3
,
Everett Meyer
3
,
Lori Muffly
3
,
Parveen Shiraz
3
,
Matthew J Frank
3
,
Andrew R Rezvani
3
,
Sushma Bharadwaj
3
,
Wen-Kai Weng
3
,
Judith A Shizuru
3
,
Sally Arai
4
Affiliations
1
University of Central Florida College of Medicine, Orlando, FL, USA.
2
Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
3
Division of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
4
Division of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA. sarai1@stanford.edu.
PMID:
39558138
DOI:
10.1038/s41409-024-02476-z
No abstract available
Publication types
Letter